Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GIST Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Not applicableStudy completedNCT03963544
What this trial is testing

Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)

Who this might be right for
Gastro Intestinal Stromal Tumor
Institut Bergonié 492
Large-scale testing (Phase 3)Ended earlyNCT00324987
What this trial is testing

Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)UnknownNCT00685828
What this trial is testing

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 946
Early research (Phase 1)Looking for participantsNCT07618377
What this trial is testing

Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments

Who this might be right for
Gastrointestinal Stromal Tumors
Ono Pharmaceutical Co., Ltd. 10
Large-scale testing (Phase 3)Ended earlyNCT00009906
What this trial is testing

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 748
Testing effectiveness (Phase 2)Looking for participantsNCT07406633
What this trial is testing

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

Who this might be right for
GIST - Gastrointestinal Stromal TumorGISTGIST Metastatic Cancer+2 more
Kumquat Biosciences Inc. 46
Not applicableStudy completedNCT06038552
What this trial is testing

Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

Who this might be right for
GIST, MalignantLiver Metastases
First Affiliated Hospital, Sun Yat-Sen University 238
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Not applicableUnknownNCT02776878
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Who this might be right for
Gastrointestinal Stromal Tumor
Peking University Cancer Hospital & Institute 57
Not applicableStudy completedNCT02171286
What this trial is testing

The Oncopanel Pilot (TOP) Study

Who this might be right for
Colorectal Cancer MetastaticAdvanced Non-Small Cell Lung CarcinomaAdvanced Melanoma+2 more
British Columbia Cancer Agency 432
Not applicableStudy completedNCT01265979
What this trial is testing

WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib

Who this might be right for
Gastrointestinal Stromal Tumors
Universitaire Ziekenhuizen KU Leuven 5
Testing effectiveness (Phase 2)Study completedNCT04193553
What this trial is testing

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Who this might be right for
Gastro Intestinal Stromal Tumour
Centre Leon Berard 77
Early research (Phase 1)WithdrawnNCT02268435
What this trial is testing

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center
Early research (Phase 1)Study completedNCT01743300
What this trial is testing

The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients

Who this might be right for
Healthy
Leiden University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00998751
What this trial is testing

Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)

Who this might be right for
Gastro-intestinal Stromal Tumours
AB Science 30
Not applicableStudy completedNCT00979381
What this trial is testing

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Who this might be right for
Renal Cell CarcinomaGIST
Radboud University Medical Center 75
Next Page